Johnson Matthey adds high containment facility in Scotland; Hospira reports mold in product

> Johnson Matthey has completed a high containment facility at its plant in Edinburgh, Scotland to manufacture potent APIs. Report

> Hospira is voluntarily recalling one lot of lactated ringer's irrigation, in the 3000mL containers after a non-invasive mold was discovered in a unit. Report 

> Edward Manookian of Hendersonville, TN, Brian Manookian of Nashville, TN and Karen Manookian of New York City have all pleaded guilty to charges related to importing from China and selling Melanotan II, an unapproved drug that was studied for treating skin cancer but is commonly used to provide a tanned appearance. Release

> CMO Pharmaceutics International of Hunt Valley, MD will build out an 18,000-square-foot expansion of its packaging facilities. Report

> The Made in the USA Foundation has filed a complaint with the FDA against large drugstore chains for failing to label the country of origin of prescription drugs, claiming that drugs from China and India are often inferior. Report

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.